UBS Group’s Elicio Therapeutics ELTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $46.5K | Sell |
6,023
-15,175
| -72% | -$117K | ﹤0.01% | 6543 |
|
|
2025
Q1 | $131K | Buy |
21,198
+21,181
| +124,594% | +$130K | ﹤0.01% | 5581 |
|
|
2024
Q4 | $87 | Sell |
17
-831
| -98% | -$4.25K | ﹤0.01% | 8419 |
|
|
2024
Q3 | $4.27K | Buy |
848
+831
| +4,888% | +$4.18K | ﹤0.01% | 6950 |
|
|
2024
Q2 | $70 | Buy |
17
+1
| +6% | +$4 | ﹤0.01% | 8041 |
|
|
2024
Q1 | $122 | Hold |
16
| – | – | ﹤0.01% | 7633 |
|
|
2023
Q4 | $133 | Hold |
16
| – | – | ﹤0.01% | 7672 |
|
|
2023
Q3 | $135 | Sell |
16
-629
| -98% | -$5.31K | ﹤0.01% | 7662 |
|
|
2023
Q2 | $6.13K | Sell |
645
-804
| -55% | -$7.64K | ﹤0.01% | 6314 |
|
|
2023
Q1 | $8.41K | Buy |
1,449
+457
| +46% | +$2.65K | ﹤0.01% | 6632 |
|
|
2022
Q4 | $8.04K | Buy |
992
+268
| +37% | +$2.17K | ﹤0.01% | 7633 |
|
|
2022
Q3 | $7K | Sell |
724
-373
| -34% | -$3.61K | ﹤0.01% | 7758 |
|
|
2022
Q2 | $12K | Buy |
1,097
+1,050
| +2,234% | +$11.5K | ﹤0.01% | 6610 |
|
|
2022
Q1 | $1K | Sell |
47
-807
| -94% | -$17.2K | ﹤0.01% | 8803 |
|
|
2021
Q4 | $25K | Buy |
+854
| New | +$25K | ﹤0.01% | 6466 |
|
|
2021
Q3 | – | Sell |
-22
| Closed | -$3K | – | 8454 |
|
|
2021
Q2 | $3K | Sell |
22
-141
| -87% | -$19.2K | ﹤0.01% | 7684 |
|
|
2021
Q1 | $29K | Buy |
+163
| New | +$29K | ﹤0.01% | 6023 |
|